To determine the current management pattern for hordeolum and chalazion among members of the Korean Society of Ophthalmic Plastic and Reconstructive Surgery (KSOPRS). An anonymous web-based survey was emailed to 260 current members of the KSOPRS. The survey comprised five sections: (1) differential diagnosis, (2) treatment strategies for hordeolum, (3) treatment strategies for chalazion, (4) postsurgical care, and (5) pediatric-specific approaches. Eighty KSOPRS members participated in this study (30.8% response rate). Redness, swelling, and pain were the most-important factors for differentiating hordeolum from chalazion. For hordeolum, topical antibiotics are preferred by 73.8% of respondents, with 83.7% considering them effective. Most (77.6%) pursue nonsurgical treatment for 5-14 days before considering incision and curettage. For chalazion, treatment practices are split between conservative management and invasive methods. Intralesional steroid injections are recommended by 68.8% of respondents, with a preference for diluted triamcinolone acetonide. Relative to hordeolum, chalazion treatment involves less-frequent antibiotic use, with only 26.3% of respondents always recommending antibiotic ointments. Tissue biopsy is considered for abnormal changes in the surrounding tissues (90%) and frequent recurrence (57.5%). The practices differ between pediatric and adult cases among 47.5% of respondents, with 81.4% extending conservative management and delaying surgical interventions in pediatric cases. Anesthesia preferences for pediatric cases varied, with 50% favoring local anesthesia, 23.8% opting for monitored anesthesia care, and 16.2% choosing general anesthesia. This survey of the management of hordeolum and chalazion by KSOPRS members has revealed several interesting common practices that are considered valuable by current practitioners.